Best Nanotechnology Stocks To Add to Your Watchlist - August 18th

Key Points

• Five nanotechnology stocks, including Onto Innovation, OSI Systems, Nano Dimension, NVE, and Clene, are highlighted as having high trading volumes and significant growth potential in the industry.
• Onto Innovation has a market cap of $5.31 billion, with recent trading showing a price of $108.27, while its P/E ratio stands at 26.84.
• Clene Inc., a clinical-stage pharmaceutical company, focuses on developing novel therapeutics and has seen its stock price reach $4.26 amidst ongoing clinical trials for its drug candidate, CNM-Au8.

Onto Innovation, OSI Systems, Nano Dimension, NVE, and Clene are the five Nanotechnology stocks to watch today, according to MarketBeat's stock screener tool. Nanotechnology stocks are shares of publicly traded companies whose core business involves research, development or commercialization of materials and devices engineered at the nanometer scale. These firms work on applications ranging from advanced materials and electronics to healthcare solutions like targeted drug delivery systems. Investors in nanotechnology stocks seek to capitalize on the industry’s high‐growth potential while weighing technical, regulatory and market risks. These companies had the highest dollar trading volume of any Nanotechnology stocks within the last several days.

Onto Innovation (ONTO)

Onto Innovation Inc. engages in the design, development, manufacture, and support of process control tools that performs optical metrology. The company offers lithography systems and process control analytical software. It also offers process and yield management solutions, and device packaging and test facilities through standalone systems for optical metrology, macro-defect inspection, packaging lithography, and transparent and opaque thin film measurements.

NYSE:ONTO traded up $1.32 during trading hours on Monday, hitting $108.27. 317,371 shares of the company's stock traded hands, compared to its average volume of 1,262,753. Onto Innovation has a 52 week low of $85.88 and a 52 week high of $228.42. The business's fifty day simple moving average is $99.68 and its two-hundred day simple moving average is $119.37. The firm has a market cap of $5.31 billion, a P/E ratio of 26.84, a P/E/G ratio of 0.72 and a beta of 1.44.

Read Our Latest Research Report on ONTO

OSI Systems (OSIS)

OSI Systems, Inc. designs and manufactures electronic systems and components. It operates in three segments: Security, Healthcare, and Optoelectronics and Manufacturing. The Security segment offers baggage and parcel inspection, cargo and vehicle inspection, hold baggage and people screening, radiation monitoring, explosive and narcotics trace detection systems, and optical inspection systems under the Rapiscan name.

Shares of OSIS traded down $1.57 during trading hours on Monday, reaching $232.71. 68,257 shares of the company's stock traded hands, compared to its average volume of 219,111. OSI Systems has a 12 month low of $129.84 and a 12 month high of $241.64. The company has a current ratio of 2.11, a quick ratio of 1.38 and a debt-to-equity ratio of 0.53. The stock has a market cap of $3.91 billion, a PE ratio of 28.31, a price-to-earnings-growth ratio of 1.98 and a beta of 1.31. The firm's 50 day simple moving average is $223.54 and its 200-day simple moving average is $210.93.

Read Our Latest Research Report on OSIS

Nano Dimension (NNDM)

Nano Dimension Ltd., together with its subsidiaries, engages in additive manufacturing solutions in Israel and internationally. The company offers 3D printers, comprising AME systems, which are inkjet printers, that produces Hi-PEDs by depositing proprietary conductive and dielectric substances, as well as integrates in-situ capacitors, antennas, coils, transformers, and electromechanical components; micro additive manufacturing systems, a digital light processing printers (DLP) that achieves production-grade polymer and composite parts; and industrial additive manufacturing systems, that utilizes a patented foil system that fabricates ceramic and metal parts.

Nano Dimension stock traded up $0.01 during mid-day trading on Monday, hitting $1.39. 1,095,755 shares of the company traded hands, compared to its average volume of 2,049,737. Nano Dimension has a one year low of $1.31 and a one year high of $2.74. The stock has a market cap of $300.93 million, a price-to-earnings ratio of -3.46 and a beta of 1.13. The stock has a fifty day moving average price of $1.47 and a 200-day moving average price of $1.72.

Read Our Latest Research Report on NNDM

NVE (NVEC)

NVE Corporation develops and sells devices that use spintronics, a nanotechnology that relies on electron spin to acquire, store, and transmit information in the United States and internationally. The company manufactures spintronic products, including sensors and couplers for use in acquiring and transmitting data.

NASDAQ:NVEC traded up $0.41 during midday trading on Monday, hitting $63.42. The company had a trading volume of 14,189 shares, compared to its average volume of 43,637. The company has a market capitalization of $306.95 million, a PE ratio of 21.14 and a beta of 1.19. NVE has a 52-week low of $51.50 and a 52-week high of $88.50. The stock's fifty day moving average price is $70.58 and its 200-day moving average price is $67.78.

Read Our Latest Research Report on NVEC

Clene (CLNN)

Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug candidate is CNM-Au8, which is being studied in various clinical trials, including a completed Phase 2 platform trial to evaluate the safety and efficacy of CNM-Au8 in patients with amyotrophic lateral sclerosis (ALS); completed Phase 2 proof of concept clinical trial in patients with early symptomatic ALS; completed two open-label investigator blinded Phase 2 clinical trials on the brain's energy metabolites; completed Phase 2 clinical trial for the treatment of visual pathway deficits in chronic optic neuropathy for remyelination in stable relapsing Multiple Sclerosis; and a second Phase 2 clinical trial for the treatment of patients with Parkinson's Diseases.

Shares of Clene stock traded up $0.64 during trading on Monday, hitting $4.26. 161,871 shares of the stock traded hands, compared to its average volume of 71,556. The stock has a market cap of $42.60 million, a price-to-earnings ratio of -1.12 and a beta of 0.55. Clene has a 52 week low of $2.28 and a 52 week high of $6.90. The firm's fifty day moving average is $3.86 and its 200-day moving average is $3.68.

Read Our Latest Research Report on CLNN

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.